查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1593908

MRI 导引神经外科消融市场：按产品、最终用户划分 - 全球预测 2025-2030 年

MRI Guided Neurosurgical Ablation Market by Product (Accessories, MRI Guided Focused Ultrasound Systems, MRI Guided Laser Ablation Systems), End User (Ambulatory Surgical Centers, Clinics, Hospitals) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年MRI导引神经外科消融市场价值为38.9亿美元，预计2024年将达到40.7亿美元，复合年增长率为4.84%，到2030年将达到54.2亿美元，预计将达到1000万美元。

MRI引导的神经外科消融的范围涉及利用MRI技术指导微创手术切除或切除脑组织。事实证明，这项技术至关重要，因为它可以精确定位疾病状态，减少对周围健康组织的潜在损害，从而改善患者的治疗效果并缩短康復时间。其应用范围广泛，包括癫痫、脑肿瘤和帕金森氏症等神经系统疾病，最终用途主要在医院、专科诊所和研究机构。关键的成长要素包括神经系统疾病的盛行率不断上升、对微创手术的需求不断增加，以及提高准确性和安全性的 MRI 技术的进步。随着医疗保健基础设施的发展和人口老化的扩大，市场成长机会也随之扩大。增强影像解读和人工智慧整合以实现个人化治疗计划是显示出创新潜力的领域。

主要市场统计
基准年[2023] 38.9亿美元
预测年份 [2024] 40.7亿美元
预测年份 [2030] 54.2亿美元
复合年增长率（%） 4.84%

然而，一些限制和挑战可能会阻碍市场成长，例如设备成本高以及对能够操作复杂技术的熟练专业人员的需求。此外，监管和报销挑战可能会阻碍市场的快速渗透，特别是在医疗保健系统欠发达的新兴市场。市场竞争激烈，主要企业在研发上投入大量资金，需要不断创新才能保持竞争力。抓住新市场机会的建议包括投资人工智慧主导平台的开发、伙伴关係以扩大技术获取，以及扩大临床试验计划以检验新的治疗应用。重点教育医学界和患者了解 MRI 导引手术的好处可以提高采用率。创新的重点是提高 MRI 导引消融的手术效率、成本效益和结果。永续成长也需要前瞻性的方法来克服监管障碍并解决报销问题。鑑于这些动态，预计市场将继续快速发展，其特点是技术进步和更多地区的采用。

市场动态：快速发展的 MRI 导引神经外科消融市场的关键市场洞察

供需的动态交互作用正在改变 MRI 导引的神经外科消融市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 由于全球人口老化迅速增加，脑肿瘤的盛行率不断增加
    • 微创神经外科手术的采用迅速增加
    • 提高患者对脑部疾病诊断和治疗的认识
  • 市场限制因素
    • MRI 导引的神经外科消融相关的高成本
  • 市场机会
    • 新兴国家医疗保健支出快速成长
    • 与神经外科消融相关的技术进步和研究活动的增加
  • 市场挑战
    • 缺乏熟练人才

波特五力：驾驭 MRI 导引神经外科消融市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解 MRI 导引神经外科消融市场的外部影响

外部宏观环境因素在塑造 MRI 导引神经外科消融市场的绩效动态方面发挥关键作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解 MRI 导引神经外科消融市场的竞争格局

对 MRI 导引神经外科消融市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵 MRI 导引神经外科消融市场供应商的绩效评估

FPNV 定位矩阵是评估 MRI 导引神经外科消融市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了 MRI 导引神经外科消融市场的成功之路

对于想要加强在全球市场的影响力的公司来说，对 MRI 导引的神经外科消融市场进行策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 随着世界人口迅速老化，脑肿瘤的发生率也增加。
      • 微创神经外科的引进迅速增加
      • 提高患者对脑部疾病诊断和治疗的认识
    • 抑制因素
      • MRI 导引的神经外科消融相关的高成本
    • 机会
      • 新兴国家医疗保健费用快速增加
      • 与神经外科消融相关的技术进步和研究活动的增加
    • 任务
      • 缺乏熟练人才
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 MRI 导引神经外科消融市场：副产品

  • 配件
  • MRI导引聚焦超音波系统
  • MRI导引雷射消熔系统
  • MRI导引射频消融系统

第 7 章 MRI 导引神经外科消融市场：依最终使用者分类

  • 门诊手术中心
  • 诊所
  • 医院

第八章北美和南美MRI引导神经外科消融市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太MRI引导神经外科消融市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第10章欧洲、中东和非洲MRI引导神经外科消融市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Boston Scientific Corporation
  • Cook Group Incorporated
  • Monteris Medical Corporation
  • Seattle Children's Hospital
  • Siemens AG
  • SternMed GmbH
Product Code: MRR-036C5CF3A877

The MRI Guided Neurosurgical Ablation Market was valued at USD 3.89 billion in 2023, expected to reach USD 4.07 billion in 2024, and is projected to grow at a CAGR of 4.84%, to USD 5.42 billion by 2030.

The scope of MRI Guided Neurosurgical Ablation encompasses the use of MRI technology to guide minimally invasive surgical procedures intended to ablate or remove predefined volumes of brain tissue. This technology proves essential as it allows for precise targeting of pathologies, reducing potential damage to surrounding healthy tissue, thereby enhancing patient outcomes and recovery times. Its applications are broad, spanning neurological disorders such as epilepsy, brain tumors, and Parkinson's disease, while the end-use segments mainly involve hospitals, specialty clinics, and research institutions. Key growth factors include increasing prevalence of neurological disorders, rising demand for minimally invasive surgeries, and advancements in MRI technology that improve accuracy and safety. As healthcare infrastructure develops and aging populations expand, opportunities for market growth similarly enlarge. Integrating artificial intelligence for enhanced imaging interpretation and personalized treatment planning represents a potential area for innovation.

KEY MARKET STATISTICS
Base Year [2023] USD 3.89 billion
Estimated Year [2024] USD 4.07 billion
Forecast Year [2030] USD 5.42 billion
CAGR (%) 4.84%

However, several limitations and challenges could inhibit market growth, such as high equipment costs and a demand for skilled professionals capable of operating complex technologies. Furthermore, regulatory and reimbursement challenges might impede swift market penetration, especially in developing regions with less robust healthcare systems. The highly competitive market landscape, with prominent players heavily investing in R&D, necessitates continuous innovation to maintain a competitive edge. Recommendations to seize emerging market opportunities include investments in AI-driven platform development, partnerships for broadening technology access, and expanding clinical trial programs to validate new therapeutic applications. Enhanced focus on educating both the medical community and patients about the benefits of MRI-guided procedures could drive adoption rates. Innovations should center on improving the procedural efficiency, cost-effectiveness, and therapeutic outcomes of MRI-guided ablations. A progressive approach to overcoming regulatory obstacles and addressing reimbursement issues is also crucial for sustainable growth. Given these dynamics, the market is expected to continue evolving rapidly, characterized by technological advancements and increasing adoption across more geographical regions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving MRI Guided Neurosurgical Ablation Market

The MRI Guided Neurosurgical Ablation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalences of brain tumors with rapidly growing geriatric population across the world
    • Surge in the adoption of minimally invasive neurosurgeries
    • Rise in the awareness of brain disorder diagnosis and treatment among patients
  • Market Restraints
    • High cost associated with the MRI guided neurosurgical ablation
  • Market Opportunities
    • Rapidly growing healthcare expenditures in emerging nations
    • Increasing technological advancement and rise in the research activities related to the neurosurgical ablation
  • Market Challenges
    • Lack of skilled manpower

Porter's Five Forces: A Strategic Tool for Navigating the MRI Guided Neurosurgical Ablation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the MRI Guided Neurosurgical Ablation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the MRI Guided Neurosurgical Ablation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the MRI Guided Neurosurgical Ablation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the MRI Guided Neurosurgical Ablation Market

A detailed market share analysis in the MRI Guided Neurosurgical Ablation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the MRI Guided Neurosurgical Ablation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the MRI Guided Neurosurgical Ablation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the MRI Guided Neurosurgical Ablation Market

A strategic analysis of the MRI Guided Neurosurgical Ablation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the MRI Guided Neurosurgical Ablation Market, highlighting leading vendors and their innovative profiles. These include Boston Scientific Corporation, Cook Group Incorporated, Monteris Medical Corporation, Seattle Children's Hospital, Siemens AG, and SternMed GmbH.

Market Segmentation & Coverage

This research report categorizes the MRI Guided Neurosurgical Ablation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Accessories, MRI Guided Focused Ultrasound Systems, MRI Guided Laser Ablation Systems, and MRI Guided RF Ablation Systems.
  • Based on End User, market is studied across Ambulatory Surgical Centers, Clinics, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalences of brain tumors with rapidly growing geriatric population across the world
      • 5.1.1.2. Surge in the adoption of minimally invasive neurosurgeries
      • 5.1.1.3. Rise in the awareness of brain disorder diagnosis and treatment among patients
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the MRI guided neurosurgical ablation
    • 5.1.3. Opportunities
      • 5.1.3.1. Rapidly growing healthcare expenditures in emerging nations
      • 5.1.3.2. Increasing technological advancement and rise in the research activities related to the neurosurgical ablation
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled manpower
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. MRI Guided Neurosurgical Ablation Market, by Product

  • 6.1. Introduction
  • 6.2. Accessories
  • 6.3. MRI Guided Focused Ultrasound Systems
  • 6.4. MRI Guided Laser Ablation Systems
  • 6.5. MRI Guided RF Ablation Systems

7. MRI Guided Neurosurgical Ablation Market, by End User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Clinics
  • 7.4. Hospitals

8. Americas MRI Guided Neurosurgical Ablation Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific MRI Guided Neurosurgical Ablation Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa MRI Guided Neurosurgical Ablation Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Boston Scientific Corporation
  • 2. Cook Group Incorporated
  • 3. Monteris Medical Corporation
  • 4. Seattle Children's Hospital
  • 5. Siemens AG
  • 6. SternMed GmbH

LIST OF FIGURES

  • FIGURE 1. MRI GUIDED NEUROSURGICAL ABLATION MARKET RESEARCH PROCESS
  • FIGURE 2. MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. MRI GUIDED NEUROSURGICAL ABLATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. MRI GUIDED NEUROSURGICAL ABLATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MRI GUIDED NEUROSURGICAL ABLATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MRI GUIDED NEUROSURGICAL ABLATION MARKET DYNAMICS
  • TABLE 7. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MRI GUIDED FOCUSED ULTRASOUND SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MRI GUIDED LASER ABLATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY MRI GUIDED RF ABLATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM MRI GUIDED NEUROSURGICAL ABLATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. MRI GUIDED NEUROSURGICAL ABLATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 103. MRI GUIDED NEUROSURGICAL ABLATION MARKET, FPNV POSITIONING MATRIX, 2023